STAA — STAAR Surgical Co Income Statement
0.000.00%
Last trade - 00:00
- $2.09bn
- $1.84bn
- $322.42m
- 84
- 11
- 74
- 57
2020 January 3rd | 2021 December 31st | 2021 January 1st | R2022 December 30th | 2023 December 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 150 | 230 | 163 | 284 | 322 |
Cost of Revenue | |||||
Gross Profit | 112 | 179 | 118 | 223 | 253 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 138 | 197 | 157 | 241 | 294 |
Operating Profit | 11.9 | 33.3 | 6.77 | 43.8 | 28.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 13 | 31.3 | 8.27 | 45.6 | 33.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14 | 24.5 | 5.91 | 39.7 | 21.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 14 | 24.5 | 5.91 | 39.7 | 21.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 14 | 24.5 | 5.91 | 39.7 | 21.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.3 | 0.495 | 0.144 | 0.804 | 0.435 |